Related Experiment Videos
Effects of permeability transition inhibition and decrease in cytochrome c content on doxorubicin toxicity in K562
F De Oliveira1, C Chauvin, X Ronot
1INSERM E-0221 Bioénergétique Fondamentale et Appliquée, Université Joseph Fourier, Grenoble, France.
Oncogene
|December 7, 2005
Summary
K562 cells resistant to doxorubicin (DOX) show inhibited mitochondrial permeability transition pore (PTP) opening and reduced cytochrome c release. These changes contribute to DOX resistance by preventing apoptosis.
Area of Science:
- Mitochondrial biology
- Cell death pathways
- Cancer chemotherapy resistance
Background:
- Mitochondria are crucial in regulating apoptosis.
- Doxorubicin (DOX) is a common chemotherapy drug that induces cell death.
- Understanding resistance mechanisms is vital for improving cancer treatment.
Purpose of the Study:
- Investigate mitochondrial changes associated with doxorubicin resistance in K562 cells.
- Determine the role of the permeability transition pore (PTP) and cytochrome c in DOX resistance.
Main Methods:
- Comparison of PTP opening, Ca2+ loading, and protein levels (cyclophilin D, cytochrome c) in DOX-sensitive and DOX-resistant K562 cells.
- Assessment of DOX-induced cell death inhibition by PTP inhibitors and siRNA targeting cytochrome c.
- Evaluation of P-glycoprotein's role in DOX resistance.
Main Results:
- DOX-resistant K562 cells exhibited inhibited PTP opening, independent of cyclosporine A (CsA).
- Cyclophilin D (CyD) levels were reduced by half in resistant cells, suggesting CsA-like PTP inhibition.
- Cytochrome c content was significantly decreased in resistant cells.
- P-glycoprotein inhibition did not restore DOX sensitivity.
Conclusions:
- Inhibition of PTP opening and reduced cytochrome c release are key mechanisms conferring DOX resistance in K562 cells.
- These mitochondrial alterations prevent DOX-induced apoptosis.